
LOC14
CAS No. 877963-94-5
LOC14( —— )
Catalog No. M20192 CAS No. 877963-94-5
LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 39 | In Stock |
![]() ![]() |
10MG | 73 | In Stock |
![]() ![]() |
25MG | 154 | In Stock |
![]() ![]() |
50MG | 279 | In Stock |
![]() ![]() |
100MG | 489 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameLOC14
-
NoteResearch use only, not for human use.
-
Brief DescriptionLOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM).
-
DescriptionLOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM).
-
In VitroCell Viability Assay Cell Line:MTEC cells Concentration:0.01 μM; 0.1 μM; 0.5 μM; 1 μM; 5 μM; 10 μM; 100 μM Incubation Time:24 hours Result:Inhibited recombinant (r)PDIA3 activity.
-
In VivoAnimal Model:Male N171–82Q HD mice Dosage:20 mg/kg Administration:Orally administered by gavage; 20 mg/kg; once daily; 12-28 weeks Result:Improved motor function in HD mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPDI
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number877963-94-5
-
Formula Weight317.4
-
Molecular FormulaC16H19N3O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:25 mg/mL?(78.76 mM)
-
SMILESO=C(C1CC1)N1CCN(Cn2sc3ccccc3c2=O)CC1
-
Chemical Name2-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]methyl]-12-benzisothiazol-3(2H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kaplan A et al. Small molecule-induced oxidation of protein disulfide isomerase is neuroprotective. Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2245-52.
molnova catalog



related products
-
GNF2133
GNF2133 is an effective and selective inhibitor of DYRK1A with IC50s of 6.2 nM. GNF2133 can be used in studies about type 1 diabetes.
-
Ethionine
Ethionine is an antimetabolite and methionine antagonist. It also produces liver neoplasms.
-
Neuropeptide S (huma...
Neuropeptide S human (TFA) is a potent endogenous neuropeptide S receptor agonist (EC50=9.4 nM).